160 related articles for article (PubMed ID: 29723269)
1. 17β-Estradiol and/or estrogen receptor alpha signaling blocks protein phosphatase 1 mediated ISO induced cardiac hypertrophy.
Fang HY; Hung MY; Lin YM; Pandey S; Chang CC; Lin KH; Shen CY; Viswanadha VP; Kuo WW; Huang CY
PLoS One; 2018; 13(5):e0196569. PubMed ID: 29723269
[TBL] [Abstract][Full Text] [Related]
2. E2/ER β inhibit ISO-induced cardiac cellular hypertrophy by suppressing Ca2+-calcineurin signaling.
Tsai CY; Kuo WW; Shibu MA; Lin YM; Liu CN; Chen YH; Day CH; Shen CY; Viswanadha VP; Huang CY
PLoS One; 2017; 12(9):e0184153. PubMed ID: 28863192
[TBL] [Abstract][Full Text] [Related]
3. 17β-Estradiol and/or estrogen receptor alpha blocks isoproterenol-induced calcium accumulation and hypertrophy via GSK3β/PP2A/NFAT3/ANP pathway.
Pai P; Velmurugan BK; Kuo CH; Yen CY; Ho TJ; Lin YM; Chen YF; Lai CH; Day CH; Huang CY
Mol Cell Biochem; 2017 Oct; 434(1-2):181-195. PubMed ID: 28577190
[TBL] [Abstract][Full Text] [Related]
4. E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis.
Lin KH; Kuo WW; Shibu MA; Day CH; Hsieh YL; Chung LC; Chen RJ; Wen SY; Viswanadha VP; Huang CY
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28441761
[TBL] [Abstract][Full Text] [Related]
5. Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER.
Goncalves GK; Scalzo S; Alves AP; Agero U; Guatimosim S; Reis AM
Am J Physiol Cell Physiol; 2018 Mar; 314(3):C310-C322. PubMed ID: 29167148
[TBL] [Abstract][Full Text] [Related]
6. Klotho attenuates isoproterenol-induced hypertrophic response in H9C2 cells by activating Na
Tang G; Shen Y; Gao P; Song SS; Si LY
In Vitro Cell Dev Biol Anim; 2018 Mar; 54(3):250-256. PubMed ID: 29344767
[TBL] [Abstract][Full Text] [Related]
7. Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Shang L; Pin L; Zhu S; Zhong X; Zhang Y; Shun M; Liu Y; Hou M
Chem Biol Interact; 2019 Jul; 307():21-28. PubMed ID: 31009642
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV protects against isoproterenol-induced cardiac hypertrophy by regulating NF-κB/PGC-1α signaling mediated energy biosynthesis.
Zhang S; Tang F; Yang Y; Lu M; Luan A; Zhang J; Yang J; Wang H
PLoS One; 2015; 10(3):e0118759. PubMed ID: 25738576
[TBL] [Abstract][Full Text] [Related]
9. 17β-Estradiol and/or Estrogen Receptor β Attenuate the Autophagic and Apoptotic Effects Induced by Prolonged Hypoxia Through HIF-1α-Mediated BNIP3 and IGFBP-3 Signaling Blockage.
Hsieh DJ; Kuo WW; Lai YP; Shibu MA; Shen CY; Pai P; Yeh YL; Lin JY; Viswanadha VP; Huang CY
Cell Physiol Biochem; 2015; 36(1):274-84. PubMed ID: 25967966
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte Proteome Remodeling due to Isoproterenol-Induced Cardiac Hypertrophy during the Compensated Phase.
Parreira RC; Gómez-Mendoza DP; de Jesus ICG; Lemos RP; Santos AK; Rezende CP; Figueiredo HCP; Pinto MCX; Kjeldsen F; Guatimosim S; Resende RR; Verano-Braga T
Proteomics Clin Appl; 2020 Jul; 14(4):e2000017. PubMed ID: 32506788
[TBL] [Abstract][Full Text] [Related]
11. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes.
Morisco C; Marrone C; Galeotti J; Shao D; Vatner DE; Vatner SF; Sadoshima J
Cardiovasc Res; 2008 Apr; 78(1):36-44. PubMed ID: 18194989
[TBL] [Abstract][Full Text] [Related]
12. Vasostatin-1 Stops Structural Remodeling and Improves Calcium Handling via the eNOS-NO-PKG Pathway in Rat Hearts Subjected to Chronic β-Adrenergic Receptor Activation.
Wang D; Shan Y; Huang Y; Tang Y; Chen Y; Li R; Yang J; Huang C
Cardiovasc Drugs Ther; 2016 Oct; 30(5):455-464. PubMed ID: 27595734
[TBL] [Abstract][Full Text] [Related]
13. Suppression of calcium‑sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy.
Liu L; Wang C; Lin Y; Xi Y; Li H; Shi S; Li H; Zhang W; Zhao Y; Tian Y; Xu C; Wang L
Mol Med Rep; 2016 Jul; 14(1):111-20. PubMed ID: 27176663
[TBL] [Abstract][Full Text] [Related]
14. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.
Fang X; Liu Y; Lu J; Hong H; Yuan J; Zhang Y; Wang P; Liu P; Ye J
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1373-1385. PubMed ID: 30132020
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation.
Bokník P; Fockenbrock M; Herzig S; Knapp J; Linck B; Lüss H; Müller FU; Müller T; Schmitz W; Schröder F; Neumann J
Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):222-31. PubMed ID: 10997724
[TBL] [Abstract][Full Text] [Related]
16. Chronic β-adrenergic stimulation reverses depressed Ca handling in mice overexpressing inhibitor-2 of protein phosphatase 1.
Kirchhefer U; Hammer E; Heinick A; Herpertz T; Isensee G; Müller FU; Neumann J; Schulte K; Seidl MD; Boknik P; Schulte JS
J Mol Cell Cardiol; 2018 Dec; 125():195-204. PubMed ID: 30389400
[TBL] [Abstract][Full Text] [Related]
17. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
Kilić A; Javadov S; Karmazyn M
J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
[TBL] [Abstract][Full Text] [Related]
18. Isoproterenol induced hypertrophy and associated signaling pathways are modulated by somatostatin in H9c2 cells.
Somvanshi RK; Qiu X; Kumar U
Int J Cardiol; 2013 Aug; 167(3):1012-22. PubMed ID: 22465343
[TBL] [Abstract][Full Text] [Related]
19. The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats.
Pelzer T; Jazbutyte V; Hu K; Segerer S; Nahrendorf M; Nordbeck P; Bonz AW; Muck J; Fritzemeier KH; Hegele-Hartung C; Ertl G; Neyses L
Cardiovasc Res; 2005 Sep; 67(4):604-12. PubMed ID: 15950203
[TBL] [Abstract][Full Text] [Related]
20. Astragalus polysaccharide inhibits isoprenaline-induced cardiac hypertrophy via suppressing Ca²⁺-mediated calcineurin/NFATc3 and CaMKII signaling cascades.
Dai H; Jia G; Liu X; Liu Z; Wang H
Environ Toxicol Pharmacol; 2014 Jul; 38(1):263-71. PubMed ID: 24975447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
